Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.......
'We seem to be in a situation where we can do little, and nothing needs to be done anyway.' Photograph: ANI Photo As India's COVID-19 daily case count dips below the 100-mark, approvals for......
Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......
The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years. "Big Boost to India's Fight......
'I'll give it to the vaccine manufacturers without guarantees, take the payment in advance and give me the supplies.''The moment you give me one lot of supply, I'll give you more.' IMAGE: A......
The markets ended flat amid a volatile trading session on Monday after elections for the 16th Lok Sabha kicked off today. Meanwhile, Sun Pharma and Ranbaxy Labs hogged the limelight after Sun......
Only five Indian companies would be in a position to choose most available redemption options for their foreign currency convertible bonds (FCCBs), due for redemption this year, according to a......
Pharma giants are going the fast moving consumer goods way, with blockbuster brands being sought after by multinational giants and even their Indian peers.Universal Remedies, which sells the......
Bharat Banka, Managing Directorand CEO, Aditya Birla Private Equity, is delighted with high net-worth individuals' rising interest in private equity. With expected returns of 25-30 per cent......